John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 2,725 shares at $1.31 ($4K) on 2022-06-21, disclosed to the SEC on 2022-06-21.
Scheduled sale ($4k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |